COVID-19 vaccine confidence in the post-vaccination era: Perceptions among adults with immune-mediated inflammatory diseases

F M Santana; R P V Rezende; N O S Paschoal; L F Rocha; J B Lopes; M O Perez; B G Bunjes; M Dório; M A D Furquim; J F Cobra; L P Sales; C P Figueiredo

doi:10.1016/j.puhip.2023.100419

COVID-19 vaccine confidence in the post-vaccination era: Perceptions among adults with immune-mediated inflammatory diseases

Public Health Pract (Oxf). 2023 Aug 9:6:100419. doi: 10.1016/j.puhip.2023.100419. eCollection 2023 Dec.

Authors

F M Santana¹, R P V Rezende^{1

2}, N O S Paschoal¹, L F Rocha¹, J B Lopes¹, M O Perez¹, B G Bunjes¹, M Dório^{1

3}, M A D Furquim^{1

3}, J F Cobra¹, L P Sales^{1

3}, C P Figueiredo^{1

3}

Affiliations

¹ Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil.
² Universidade Federal Fluminense, Divisão de Reumatologia, Departamento de Medicina Clínica (MMC), Niterói, Rio de Janeiro, Brazil.
³ Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Abstract

Objective: Assess the perceived protection afforded by a range of COVID-19 vaccines in immune-mediated inflammatory diseases patients previously vaccinated against SARS-CoV-2.

Study design: Survey.

Methods: On-line cross-sectional survey aimed at evaluating the perceived protection (and its determinants) afforded by a range of COVID-19 vaccines among immune-mediated inflammatory diseases previously vaccinated for COVID-19.

Results: Out of 493 eligible respondents who lived in Brazil, 397 (80.5%) were confident that their primary vaccination series would protect them against severe COVID-19. In multivariate analysis, only overlapping immune-mediated inflammatory diseases remained (negatively) associated with the perception of protection.

Conclusions: No influence was found between COVID-19 vaccine types and the perception of protection after initial vaccinations.

Keywords: COVID-19; COVID-19 vaccine; Confidence; Immune-mediated inflammatory diseases; Protection; SARS-CoV-2.